These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18480692)

  • 21. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin in the treatment of posttraumatic stress disorder: a case report.
    Paslakis G; Gilles M; Deuschle M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1160-1. PubMed ID: 21338648
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports.
    Hitiris N; Barrett JA; Brodie MJ
    Epilepsy Behav; 2006 Mar; 8(2):418-21. PubMed ID: 16446121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin in the treatment of schizophrenic anxiety.
    Schönfeldt-Lecuona C; Wolf RC; Osterfeld ND; Vasic N; Connemann BJ; Schmid M; Freudenmann RW
    Pharmacopsychiatry; 2009 May; 42(3):124-5. PubMed ID: 19452382
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.
    Stein DJ; Baldwin DS; Baldinetti F; Mandel F
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):422-30. PubMed ID: 18359203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive pregabalin to quetiapine in acute mania.
    Oulis P; Florakis AA; Tzanoulinos G; Papadimitriou GN
    Clin Neuropharmacol; 2009; 32(3):174. PubMed ID: 19483492
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.
    Schaffer A; Zuker P; Levitt A
    J Affect Disord; 2006 Nov; 96(1-2):95-9. PubMed ID: 16820213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-life citalopram-induced impairments in sexual behavior and the role of androgen receptor.
    Soga T; Wong DW; Putteeraj M; Song KP; Parhar IS
    Neuroscience; 2012 Dec; 225():172-84. PubMed ID: 22960312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citalopram and suicidality in adult major depression and anxiety disorders.
    Pedersen AG
    Nord J Psychiatry; 2006; 60(5):392-9. PubMed ID: 17038305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety profile of treatment in diabetic peripheral neuropathic pain.
    Robinson-Papp J; Simpson DM
    Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
    Stevens JC; Pollack MH
    J Clin Psychiatry; 2005; 66 Suppl 2():21-7. PubMed ID: 15762816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
    Baldwin DS; Schweizer E; Xu Y; Lyndon G
    Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.